The epidemiology of Parkinson's disease
Yoav Ben‐Shlomo(University of Bristol), Caroline M. Tanner(University of California, San Francisco), Sirwan K.L. Darweesh(Radboud University Nijmegen), Marta San Luciano(University of California, San Francisco), Connie Marras(University of Toronto), Jorge J. Llibre‐Guerra(Washington University in St. Louis)
Cited by 809
Related Papers
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2016|390
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|364
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
|Brain|2021|190
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
|The Lancet Neurology|2017|189